行情

AXGN

AXGN

Axogen Inc.
NASDAQ

实时行情|Nasdaq Last Sale

14.15
-0.07
-0.49%
盘后: 14.15 0 0.00% 16:41 09/20 EDT
开盘
14.18
昨收
14.22
最高
14.42
最低
14.02
成交量
60.13万
成交额
--
52周最高
39.33
52周最低
11.82
市值
5.55亿
市盈率(TTM)
-21.2846
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AXGN 新闻

  • 德国银行业协会预计该国GDP增长率为0.5%
  • 新浪美股.2小时前
  • 特朗普呼吁将利率降至零以下:我们应比别人少付利息
  • 新浪美股.3小时前
  • 网易“潜伏”海外:攻占日韩 “出师”印度 远征非洲
  • 新浪美股.3小时前
  • 股价迄今飙升超300% Roku投资者为何急跳墙?
  • 新浪财经-自媒体综合.4小时前

更多

所属板块

先进医疗设备和技术
-0.70%
医疗设备和用品
-0.22%

热门股票

名称
价格
涨跌幅

AXGN 简况

AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along with these core surgical products, the Company also offers the AxoTouch Two-Point Discriminator, and AcroVal Neurosensory and Motor Testing System. These evaluation and measurement tools assist healthcare professionals in detecting changes in sensation; assessing return of sensory, grip and pinch function; evaluating treatment interventions, and providing feedback to patients on nerve function. Its portfolio of products is available in the United States, Canada, the United Kingdom and several European and other countries. The Company's products are used by surgeons during surgical interventions to repair a range of nerve injuries throughout the body.
展开

Webull提供Axogen Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。